Huntington Bancshares, Inc (HBAN): A Great Stock For Handling Current Market Conditions?

Currently, there are 1.46B common shares owned by the public and among those 1.44B shares have been available to trade.

The company’s stock has a 5-day price change of 5.34% and -16.28% over the past three months. HBAN shares are trading -11.49% year to date (YTD), with the 12-month market performance up to 5.65% higher. It has a 12-month low price of $11.91 and touched a high of $18.44 over the same period. HBAN has an average intraday trading volume of 23.82 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.83%, -2.77%, and -6.93% respectively.

Institutional ownership of Huntington Bancshares, Inc (NASDAQ: HBAN) shares accounts for 85.84% of the company’s 1.46B shares outstanding.

It has a market capitalization of $21.03B and a beta (3y monthly) value of 0.92. The stock’s trailing 12-month PE ratio is 11.08, while the earnings-per-share (ttm) stands at $1.30. The company has a PEG of 0.86 and the debt-to-equity ratio at 0.92. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.82% over the week and 4.89% over the month.

Earnings per share for the fiscal year are expected to increase by 16.83%, and 10.61% over the next financial year. EPS should grow at an annualized rate of 12.94% over the next five years, compared to -0.74% over the past 5-year period.

Looking at the support for the HBAN, a number of firms have released research notes about the stock. Deutsche Bank stated their Buy rating for the stock in a research note on April 24, 2025, with the firm’s price target at $17.50. Robert W. Baird coverage for the Huntington Bancshares, Inc (HBAN) stock in a research note released on March 07, 2025 offered a Outperform rating with a price target of $18. JP Morgan was of a view on December 04, 2024 that the stock is Overweight, while Robert W. Baird gave the stock Neutral rating on July 26, 2024, issuing a price target of $15. Piper Sandler on their part issued Underweight rating on June 14, 2024.

Most Popular

Related Posts